| scholarly article | Q13442814 |
| P50 | author | Clara Menéndez | Q58876158 |
| Jaume Ordi | Q59146714 | ||
| P2093 | author name string | Alonso PL | |
| Aponte JJ | |||
| Font F | |||
| Ismail MR | |||
| Kahigwa E | |||
| Ventura PJ | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | birth mass | Q4128476 |
| maternal health | Q6786626 | ||
| malaria | Q12156 | ||
| P304 | page(s) | 1740-1745 | |
| P577 | publication date | 2000-05-15 | |
| P1433 | published in | Journal of Infectious Diseases | Q4051141 |
| P1476 | title | The impact of placental malaria on gestational age and birth weight | |
| P478 | volume | 181 |
| Q49431533 | A brief review on features of falciparum malaria during pregnancy |
| Q54941549 | A comparative study of pregnancy complications and outcomes for the years 1999 and 2004 at a rural hospital in South Africa: Implications for antenatal care. |
| Q36737343 | A model of parity-dependent immunity to placental malaria. |
| Q34425614 | A novel histological grading scheme for placental malaria applied in areas of high and low malaria transmission |
| Q33327356 | A randomized placebo-controlled trial of intermittent preventive treatment in pregnant women in the context of insecticide treated nets delivered through the antenatal clinic |
| Q34031788 | A targeted association study of immunity genes and networks suggests novel associations with placental malaria infection. |
| Q36793324 | Abundance of megalin and Dab2 is reduced in syncytiotrophoblast during placental malaria, which may contribute to low birth weight |
| Q89884556 | Accumulation of CD4 and CD8 T Cells in Placenta of Malaria Infected Mice Induces the Expression of Hypoxia Inducible Factor-1α (HIF-1α) and Low Birth Weight (LBW) of the Fetus |
| Q39116049 | Adverse birth outcomes in a malarious area |
| Q33328938 | Adverse pregnancy outcomes in an area where multidrug-resistant plasmodium vivax and Plasmodium falciparum infections are endemic |
| Q38959038 | Amodiaquine, malaria, pregnancy: the old new drug |
| Q35296614 | Anthropometry of fetal growth in rural Malawi in relation to maternal malaria and HIV status |
| Q37382365 | Antibodies to variant surface antigens of Plasmodium falciparum-infected erythrocytes are associated with protection from treatment failure and the development of anemia in pregnancy |
| Q36644765 | Artemether-Lumefantrine Pharmacokinetics and Clinical Response Are Minimally Altered in Pregnant Ugandan Women Treated for Uncomplicated Falciparum Malaria. |
| Q36368036 | Artemether-lumefantrine to treat malaria in pregnancy is associated with reduced placental haemozoin deposition compared to quinine in a randomized controlled trial |
| Q64107927 | Artemisinin-based combination therapy during pregnancy: outcome of pregnancy and infant mortality: a cohort study |
| Q64241973 | Association of Malaria Infection During Pregnancy With Head Circumference of Newborns in the Brazilian Amazon |
| Q37686396 | Asymptomatic Plasmodium falciparum infection is associated with anaemia in pregnancy and can be more cost-effectively detected by rapid diagnostic test than by microscopy in Kinshasa, Democratic Republic of the Congo |
| Q34479077 | Biomarkers of Plasmodium falciparum infection during pregnancy in women living in northeastern Tanzania. |
| Q92563835 | Biosensors for Detection of Human Placental Pathologies: A Review of Emerging Technologies and Current Trends |
| Q26824358 | Body iron delocalization: the serious drawback in iron disorders in both developing and developed countries |
| Q33420846 | C5a enhances dysregulated inflammatory and angiogenic responses to malaria in vitro: potential implications for placental malaria. |
| Q37607811 | CD20, CD3, placental malaria infections and low birth weight in an area of unstable malaria transmission in Central Sudan |
| Q37625184 | Characterization of human placental glycosaminoglycans and regional binding to VAR2CSA in malaria infected erythrocytes |
| Q35855583 | Chondroitin sulfate proteoglycan but not hyaluronic acid is the receptor for the adherence of Plasmodium falciparum-infected erythrocytes in human placenta, and infected red blood cell adherence up-regulates the receptor expression |
| Q34934975 | Chondroitin sulfate proteoglycan expression and binding of Plasmodium falciparum-infected erythrocytes in the human placenta during pregnancy. |
| Q33702586 | Chronic infection during placental malaria is associated with up-regulation of cycloxygenase-2. |
| Q34037890 | Circulating soluble endoglin levels in pregnant women in Cameroon and Malawi--associations with placental malaria and fetal growth restriction |
| Q36496472 | Clinical malaria in African pregnant women |
| Q35947334 | Coagulation and Fibrinolysis Indicators and Placental Malaria Infection in an Area Characterized by Unstable Malaria Transmission in Central Sudan |
| Q37211417 | Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment |
| Q35568864 | Complement activation, placental malaria infection, and birth weight in areas characterized by unstable malaria transmission in central Sudan |
| Q52755953 | Congenital Malaria In Newborn Twins |
| Q36775697 | Congenital Plasmodium falciparum infection in neonates in Muheza District, Tanzania |
| Q34363140 | Congenital malaria in newborn twins |
| Q91638677 | Contribution of Murine Models to the Study of Malaria During Pregnancy |
| Q98735920 | Cord Malaria Infection, Complement Activation, Oxidative Stress, Gestational Age, and Birth Weight, Characterized by High Plasmodium falciparum Prevalence in Bamenda, Cameroon |
| Q28475795 | Cost-effectiveness of intermittent preventive treatment of malaria in pregnancy in southern Mozambique |
| Q35025311 | Coverage of intermittent prevention treatment with sulphadoxine-pyrimethamine among pregnant women and congenital malaria in Côte d'Ivoire |
| Q37735182 | Current knowledge and challenges of antimalarial drugs for treatment and prevention in pregnancy |
| Q36306679 | Cytokine expression in malaria-infected non-human primate placentas |
| Q36327851 | Decline of placental malaria in southern Ghana after the implementation of intermittent preventive treatment in pregnancy |
| Q39705543 | Decrease of microscopic Plasmodium falciparum infection prevalence during pregnancy following IPTp-SP implementation in urban cities of Gabon |
| Q35250816 | Detection and clinical manifestation of placental malaria in southern Ghana |
| Q93010101 | Determinants of preterm birth among mothers who gave birth in East Africa: systematic review and meta-analysis |
| Q39245566 | Development of vaccines to prevent malaria in pregnant women: WHO MALVAC meeting report |
| Q35947173 | Developmental stage- and cell cycle number-dependent changes in characteristics of Plasmodium falciparum-infected erythrocyte adherence to placental chondroitin-4-sulfate proteoglycan |
| Q33946960 | Diagnosis of placental malaria |
| Q37242538 | Diagnostic comparison of malaria infection in peripheral blood, placental blood and placental biopsies in Cameroonian parturient women |
| Q34310322 | Differential association of gene content polymorphisms of killer cell immunoglobulin-like receptors with placental malaria in HIV- and HIV+ mothers |
| Q24241218 | Drugs for treating uncomplicated malaria in pregnant women |
| Q24246287 | Drugs for treating uncomplicated malaria in pregnant women |
| Q33733730 | Effect of IPTp on Plasmodium falciparum antibody levels among pregnant women and their babies in a sub-urban coastal area in Ghana |
| Q34083463 | Effect of prenatal zinc supplementation on birthweight |
| Q33757461 | Effects of HIV infection on maternal and neonatal health in southern Mozambique: A prospective cohort study after a decade of antiretroviral drugs roll out. |
| Q64260021 | Effects of a health educational intervention on malaria knowledge, motivation, and behavioural skills: a randomized controlled trial |
| Q39569746 | Estimated risk of placental infection and low birthweight attributable to Plasmodium falciparum malaria in Africa in 2010: a modelling study. |
| Q91214784 | Estimating malaria burden among pregnant women using data from antenatal care centres in Tanzania: a population-based study |
| Q33873623 | Evaluation of the effectiveness and compliance of intermittent preventive treatment (IPT) in the control of malaria in pregnant women in south eastern Nigeria |
| Q47862113 | Evolutionary analysis of genes of two pathways involved in placental malaria infection |
| Q54676246 | Experimental genital mycoplasmosis causes increased levels of mRNA for IL-6 and TNF-alpha in the placenta. |
| Q50026713 | Fetal and Maternal Innate Immunity Receptors Have Opposing Effects on the Severity of Experimental Malaria in Pregnancy: Beneficial Roles for Fetus-Derived Toll-Like Receptor 4 and Type I Interferon Receptor 1. |
| Q36936419 | Flt1, pregnancy, and malaria: evolution of a complex interaction |
| Q39548562 | Forecasting burden of long-term disability from neonatal conditions: results from the Projahnmo I trial, Sylhet, Bangladesh |
| Q30227236 | Global report on preterm birth and stillbirth (3 of 7): evidence for effectiveness of interventions |
| Q34009705 | Gravidity-dependent production of antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to placental chondroitin sulfate proteoglycan during pregnancy |
| Q34171651 | HIV-1 inhibits phagocytosis and inflammatory cytokine responses of human monocyte-derived macrophages to P. falciparum infected erythrocytes |
| Q37623785 | Hemozoin differentially regulates proinflammatory cytokine production in human immunodeficiency virus-seropositive and -seronegative women with placental malaria |
| Q36088581 | Heterologous Infection of Pregnant Mice Induces Low Birth Weight and Modifies Offspring Susceptibility to Malaria |
| Q33806360 | Histopathologies, immunolocalization, and a glycan binding screen provide insights into Plasmodium falciparum interactions with the human placenta |
| Q37866662 | How many low birthweight babies in low- and middle-income countries are preterm? |
| Q53819699 | IgM and IgG against Plasmodium falciparum lysate as surrogates of malaria exposure and protection during pregnancy. |
| Q36498853 | Immunologic activation of human syncytiotrophoblast by Plasmodium falciparum |
| Q34764578 | Impact of malaria at the end of pregnancy on infant mortality and morbidity |
| Q35920636 | Impact of malaria during pregnancy on low birth weight in sub-Saharan Africa |
| Q36811690 | Impact of malaria during pregnancy on pregnancy outcomes in a Ugandan prospective cohort with intensive malaria screening and prompt treatment |
| Q46578577 | Impact of maternal malaria and under-nutrition on intrauterine growth restriction: a prospective ultrasound study in Democratic Republic of Congo |
| Q36274941 | Impact of placental Plasmodium falciparum malaria on pregnancy and perinatal outcome in sub-Saharan Africa: I: introduction to placental malaria |
| Q36470408 | Impact of placental Plasmodium falciparum malaria on pregnancy and perinatal outcome in sub-Saharan Africa: II: effects of placental malaria on perinatal outcome; malaria and HIV. |
| Q33380234 | Impact of placental Plasmodium falciparum malaria on pregnancy and perinatal outcome in sub-Saharan Africa: part III: placental malaria, maternal health, and public health. |
| Q35187064 | Importance and prevention of malaria in pregnancy |
| Q35292227 | Infection before pregnancy affects immunity and response to social challenge in the next generation |
| Q28543146 | Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-negative women: a multicentre randomized controlled trial |
| Q34525497 | Intervillous macrophage migration inhibitory factor is associated with adverse birth outcomes in a study population in Central India |
| Q47981266 | Intrauterine growth retardation, low birth weight and prematurity in neonates of pregnant women with malaria in Colombia |
| Q35677598 | Is chloroquine chemoprophylaxis still effective to prevent low birth weight? Results of a study in Benin |
| Q35500954 | Knowledge, attitudes, and practices concerning malaria in pregnancy: results from a qualitative study in Madang, Papua New Guinea |
| Q37521633 | Lack of an association between antibodies to Plasmodium falciparum glycosylphosphatidylinositols and malaria-associated placental changes in Cameroonian women with preterm and full-term deliveries |
| Q58422369 | Leptin, insulin like growth factor-I levels and histology-diagnosed placental malaria in an area characterized by unstable malaria transmission in central Sudan |
| Q36000539 | Low coverage of intermittent preventive treatment for malaria in pregnancy in Nigeria: demand-side influences |
| Q36891500 | Macrophage migration inhibitory factor and placental malaria infection in an area characterized by unstable malaria transmission in central Sudan |
| Q35751895 | Malaria burden in pregnancy at mulago national referral hospital in kampala, Uganda |
| Q24815923 | Malaria during pregnancy and foetal haematological status in Blantyre, Malawi |
| Q39460324 | Malaria in pregnancy: adverse effects on haemoglobin levels and birthweight in primigravidae and multigravidae |
| Q36717621 | Malaria in pregnancy: pathogenesis and immunity |
| Q41990397 | Malaria in pregnancy: the relevance of animal models for vaccine development. |
| Q36817795 | Malaria in pregnant women in an area with sustained high coverage of insecticide-treated bed nets |
| Q37409590 | Malaria-induced murine pregnancy failure: distinct roles for IFN-gamma and TNF. |
| Q47797899 | Management of malaria in pregnancy |
| Q34162714 | Maternal malaria induces a procoagulant and antifibrinolytic state that is embryotoxic but responsive to anticoagulant therapy |
| Q35885667 | Maternal malaria status and metabolic profiles in pregnancy and in cord blood: relationships with birth size in Nigerian infants |
| Q34023644 | Maternal malaria, birth size and blood pressure in Nigerian newborns: insights into the developmental origins of hypertension from the Ibadan growth cohort |
| Q64985715 | Maternal-Fetal Conflict During Infection: Lessons From a Mouse Model of Placental Malaria. |
| Q24599164 | Mefloquine safety and tolerability in pregnancy: a systematic literature review |
| Q34610759 | Molecular Detection of Plasmodium falciparum Infection in Matched Peripheral and Placental Blood Samples from Delivering Women in Libreville, Gabon |
| Q64076612 | Molecular Principles of Intrauterine Growth Restriction in Plasmodium Falciparum Infection |
| Q35241127 | Monocytes and macrophages and placental malaria infections in an area of unstable malaria transmission in eastern Sudan |
| Q28550346 | Mortality, Morbidity, and Developmental Outcomes in Infants Born to Women Who Received Either Mefloquine or Sulfadoxine-Pyrimethamine as Intermittent Preventive Treatment of Malaria in Pregnancy: A Cohort Study |
| Q43949013 | Neonatal morbidity and mortality in a Tanzanian tertiary care referral hospital |
| Q36980850 | New approaches to pathogenesis of malaria in pregnancy. |
| Q36073865 | Nrf2-driven CD36 and HO-1 gene expression in circulating monocytes correlates with favourable clinical outcome in pregnancy-associated malaria |
| Q36300046 | Option B+ for prevention of vertical HIV transmission has no influence on adverse birth outcomes in a cross-sectional cohort in Western Uganda |
| Q33870976 | Outcomes of asymptomatic malaria parasitaemia in neonates in a tertiary hospital, southeast Nigeria |
| Q56435439 | Oxidative Stress: A Potential Therapeutic Target in Placental Malaria |
| Q97570319 | PREVALENCE OF MALARIA PARASITAEMIA AND THE USE OF MALARIA PREVENTION MEASURES IN PREGNANT WOMEN IN IBADAN, NIGERIA |
| Q35212899 | Parasite accumulation in placenta of non-immune baboons during Plasmodium knowlesi infection |
| Q35881400 | Parasitemia Induces High Plasma Levels of Interleukin-17 (IL-17) and Low Levels of Interleukin-10 (IL-10) and Transforming Growth Factor-ß (TGF-ß) in Pregnant Mice Infected with Malaria |
| Q36818201 | Performance of the OptiMAL dipstick in the diagnosis of malaria infection in pregnancy |
| Q37505555 | Peripheral blood mononuclear cells derived from grand multigravidae display a distinct cytokine profile in response to P. falciparum infected erythrocytes |
| Q41937695 | Pharmacodynamics of antimalarial chemotherapy |
| Q34669043 | Pharmacokinetics and pharmacodynamics of artesunate and dihydroartemisinin following oral treatment in pregnant women with asymptomatic Plasmodium falciparum infections in Kinshasa DRC. |
| Q40100988 | Placental Malaria: A New Insight into the Pathophysiology |
| Q34239965 | Placental histopathologic changes associated with subclinical malaria infection and its impact on the fetal environment |
| Q33786153 | Placental infections with histologically confirmed Plasmodium falciparum are associated with adverse birth outcomes in India: a cross-sectional study |
| Q37402159 | Placental malaria and low birth weight in pregnant women living in a rural area of Burkina Faso following the use of three preventive treatment regimens |
| Q44424266 | Placental malaria and the relationship to pregnancy outcome at Gushegu District Hospital, Northern Ghana |
| Q37213052 | Placental malaria and the risk of malaria in infants in a high malaria transmission area in Ghana: A prospective cohort study |
| Q33738991 | Placental malaria is associated with reduced early life weight development of affected children independent of low birth weight |
| Q34530051 | Placental tumor necrosis factor alpha but not gamma interferon is associated with placental malaria and low birth weight in Malawian women |
| Q35812804 | Plasmodium chabaudi AS induces pregnancy loss in association with systemic pro-inflammatory immune responses in A/J and C57BL/6 mice |
| Q37428342 | Plasmodium falciparum exposure in utero, maternal age and parity influence the innate activation of foetal antigen presenting cells. |
| Q43924333 | Plasmodium falciparum infection early in pregnancy has profound consequences for foetal growth |
| Q38930697 | Plasmodium falciparum infection in pregnant women attending antenatal care in Luanda, Angola |
| Q34585683 | Plasmodium falciparum malaria elicits inflammatory responses that dysregulate placental amino acid transport |
| Q36394496 | Plasmodium falciparum parasitaemia in the first half of pregnancy, uterine and umbilical artery blood flow, and foetal growth: a longitudinal Doppler ultrasound study |
| Q35098438 | Plasmodium falciparum-infected erythrocytes adhere both in the intervillous space and on the villous surface of human placenta by binding to the low-sulfated chondroitin sulfate proteoglycan receptor |
| Q34995291 | Pooled PCR testing strategy and prevalence estimation of submicroscopic infections using Bayesian latent class models in pregnant women receiving intermittent preventive treatment at Machinga District Hospital, Malawi, 2010 |
| Q37351962 | Predictors of fetal anemia and cord blood malaria parasitemia among newborns of HIV-positive mothers |
| Q96121253 | Pregnancy outcomes and risk of placental malaria after artemisinin-based and quinine-based treatment for uncomplicated falciparum malaria in pregnancy: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-an |
| Q35121217 | Pregnancy, Nutrition and Parasitic Diseases |
| Q37258037 | Pregnancy-Associated Malaria in a Rural Community of Ghana |
| Q47874603 | Pregnancy-associated malaria affects toll-like receptor ligand-induced cytokine responses in cord blood |
| Q33963392 | Pregnancy-associated malaria and malaria in infants: an old problem with present consequences |
| Q36343129 | Prevalence of Plasmodium falciparum Malaria among Pregnant Students in Dodoma Region, Tanzania: No Cases Have Been Detected |
| Q41924819 | Prevalence of Plasmodium falciparum, anemia and molecular markers of chloroquine and sulfadoxine-pyriméthamine resistance in delivered women in Fana, Mali |
| Q35923275 | Prevalence of parasitic infections and associations with pregnancy complications and outcomes in northern Tanzania: a registry-based cross-sectional study |
| Q37624137 | Prevalence of peripheral blood parasitaemia, anaemia and low birthweight among pregnant women in a suburban area in coastal Ghana |
| Q44270197 | Prevalence, risk factors and effects of placental malaria in the UMTH, Maiduguri, North-eastern, Nigeria: a cross-sectional study |
| Q33754488 | Protective efficacy of interventions for preventing malaria mortality in children in Plasmodium falciparum endemic areas |
| Q36980837 | Protozoan and helminth infections in pregnancy. Short-term and long-term implications of transmission of infection from mother to foetus |
| Q33450639 | Recrudescent Plasmodium berghei from pregnant mice displays enhanced binding to the placenta and induces protection in multigravida |
| Q40376689 | Recruited monocytes modulate malaria-induced lung injury through CD36-mediated clearance of sequestered infected erythrocytes. |
| Q44311846 | Reduced prevalence of Plasmodium falciparum infection and of concomitant anaemia in pregnant women with heterozygous G6PD deficiency |
| Q36717628 | Reducing the burden of malaria in pregnancy by preventive strategies |
| Q41990717 | Relationships between infection with Plasmodium falciparum during pregnancy, measures of placental malaria, and adverse birth outcomes |
| Q57013711 | Response to Ordi et al |
| Q44993684 | Risk factors and mechanisms of preterm delivery in Malawi |
| Q42634261 | Risk factors and pregnancy outcomes associated with placental malaria in a prospective cohort of Papua New Guinean women |
| Q41250135 | Risk factors for malaria and adverse birth outcomes in a prospective cohort of pregnant women resident in a high malaria transmission area of Papua New Guinea. |
| Q36713881 | Role of chondroitin-4-sulfate in pregnancy-associated malaria |
| Q34187263 | Role of oxidative stress and apoptosis in the placental pathology of Plasmodium berghei infected mice |
| Q30827703 | Scaling-up the use of sulfadoxine-pyrimethamine for the preventive treatment of malaria in pregnancy: results and lessons on scalability, costs and programme impact from three local government areas in Sokoto State, Nigeria |
| Q35666823 | Sequestration: causes and consequences |
| Q34745250 | Soluble CD163, a product of monocyte/macrophage activation, is inversely associated with haemoglobin levels in placental malaria |
| Q34531233 | Spontaneous postpartum clearance of Plasmodium falciparum parasitemia in pregnant women, Benin |
| Q46738799 | Statistical modelling of the seasonality of preterm delivery and intrauterine growth restriction in rural Gambia |
| Q91971710 | Sticking for a Cause: The Falciparum Malaria Parasites Cytoadherence Paradigm |
| Q38307897 | Structural basis for the adherence of Plasmodium falciparum-infected erythrocytes to chondroitin 4-sulfate and design of novel photoactivable reagents for the identification of parasite adhesive proteins |
| Q37104991 | Structural interactions in chondroitin 4-sulfate mediated adherence of Plasmodium falciparum infected erythrocytes in human placenta during pregnancy-associated malaria |
| Q37077688 | Sub-microscopic infections and long-term recrudescence of Plasmodium falciparum in Mozambican pregnant women |
| Q36898262 | Submicroscopic Plasmodium falciparum malaria and low birth weight in an area of unstable malaria transmission in Central Sudan |
| Q36261056 | Syncytiotrophoblast Functions and Fetal Growth Restriction during Placental Malaria: Updates and Implication for Future Interventions |
| Q37693621 | The Effect of Mass Media Campaign on the Use of Insecticide-Treated Bed Nets among Pregnant Women in Nigeria |
| Q34461507 | The Malaria in Pregnancy Library: a bibliometric review. |
| Q60305299 | The Rough Guide to Monocytes in Malaria Infection |
| Q46811065 | The association of anti-phospholipid antibodies with parity in placental malaria |
| Q30396100 | The combined effect of determinants on coverage of intermittent preventive treatment of malaria during pregnancy in the Kilombero Valley, Tanzania |
| Q80393538 | The effect of substitution of the N-acetyl groups of N-acetylgalactosamine residues in chondroitin sulfate on its degradation by chondroitinase ABC |
| Q36834270 | The effect of timing and frequency of Plasmodium falciparum infection during pregnancy on the risk of low birth weight and maternal anemia |
| Q35819293 | The effectiveness and perception of the use of sulphadoxine-pyrimethamine in intermittent preventive treatment of malaria in pregnancy programme in Offinso district of Ashanti region, Ghana |
| Q35162525 | The epidemiology and consequences of maternal malaria: a review of immunological basis |
| Q21032461 | The impact of maternal malaria on newborns |
| Q33849067 | The role of Plasmodium falciparum var genes in malaria in pregnancy. |
| Q35896245 | The role of prophylactic antimalarial in the reduction of placental parasitemia among pregnant women in Calabar, Nigeria |
| Q34944810 | Therapeutic efficacy of sulphadoxine-pyrimethamine and chloroquine for the treatment of uncomplicated malaria in pregnancy in Burkina Faso. |
| Q36583907 | Timing of malaria in pregnancy and impact on infant growth and morbidity: a cohort study in Uganda |
| Q46265974 | Towards a needle-free diagnosis of malaria: in vivo identification and classification of red and white blood cells containing haemozoin |
| Q37053822 | Treatment and prevention of malaria in pregnancy and newborn |
| Q48036116 | Treatment and prevention of malaria in pregnancy: opportunities and challenges. |
| Q38870452 | Treatment regimens for pregnant women with falciparum malaria |
| Q34637039 | Uptake of intermittent preventive treatment with sulphadoxine-pyrimethamine for malaria during pregnancy and pregnancy outcomes: a cross-sectional study in Geita district, North-Western Tanzania |
| Q37554737 | Usefulness of a biomarker to identify placental dysfunction in the context of malaria |
| Q33751699 | Utilisation of insecticide treated nets among pregnant women in Gulu: a post conflict district in northern Uganda |
| Q34921119 | VAR2CSA signatures of high Plasmodium falciparum parasitemia in the placenta |
| Q46512891 | Weighing in on malaria-attributable low birthweight in Africa |
Search more.